Molecular identification of multiple drug resistance (MDR) strain of Mycobacterium tuberculosis

被引:0
作者
Zahra Hosseinali
Jafar Mohammadshahi
Amir Teimourpour
Shahram Habibzadeh
Majid Esmaelizad
Mohsen Arzanlou
Hafez Mirzanejad-Asl
Mahin Sadeghnezhad
Shabnam Sohrabi
Roghayeh Teimourpour
机构
[1] Ardabil University of Medical Sciences,Department of Microbiology, School of Medicine
[2] Ardabil University of Medical Sciences,Departments of infectious disease, School of Medicine
[3] Razi Vaccine and Serum Research Institute,Central lab
[4] Ardabil University of Medical Sciences,Zoonoses Research Center
[5] Ardabil University of Medical Sciences,Ardabil Health Center
[6] High Institute for Research and Education,Blood Transfusion Research Center
来源
Molecular Biology Reports | 2023年 / 50卷
关键词
PCR; Isoniazid; Rifampin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:10271 / 10275
页数:4
相关论文
共 62 条
[1]  
Tiberi S(2022)Drug resistant TB–latest developments in epidemiology, diagnostics and management Int J Infect Dis 124 S20-S5
[2]  
Utjesanovic N(2022)Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis PLoS ONE 17 e0270003-13
[3]  
Galvin J(2021)HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis BMC Infect Dis 21 1-137
[4]  
Centis R(2021)Prevalence of latent tuberculosis infection among health workers in Afghanistan: a cross-sectional study PLoS ONE 16 e0252307-62
[5]  
D’Ambrosio L(2020)Prevalence of multi-drug resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa–a high tuberculosis endemic area of Pakistan Pol J Microbiol 69 133-13
[6]  
van den Boom M(2012)Detection of genomic mutations in katG, inhA and rpoB genes of Mycobacterium tuberculosis isolates using polymerase chain reaction and multiplex allele-specific polymerase chain reaction Brazilian J Infect Dis 16 57-1801
[7]  
Xi Y(2019)Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB Eur J Med Res 24 1-66
[8]  
Zhang W(2015)WHO’s new end TB strategy The Lancet 385 1799-e34
[9]  
Qiao R-J(2022)TB elimination program (NTEP): at a glance J Association Chest Physicians 10 55-606
[10]  
Tang J(2011)Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran Am J Ther 18 e29-103